
The Nanōmix Asthma Management SystemNanōmix Sensation™ technology is enabling a new non-invasive device for asthma monitoring that measures exhaled nitrous oxide, a biomarker that has been shown to be well correlated well with asthma inflammation. Asthma is an inflammatory airway disease that affects over 20 million people in the United States. Until recently, there was no reliable and convenient way for patients to assess airway inflammation on a regular basis. The Nanōmix Asthma Management System is a desktop device that measures the level of nitric oxide (NO) in exhaled breath. It provides a rapid, convenient measure of inflammation that could significantly improve the diagnosis and treatment of asthma. |
|
Nanōmix Asthma Management System
|
A prototype of the Nanōmix
Asthma Management System (SEE THE VIDEO) |